To view the PDF file, sign up for a MySharenet subscription.

MEDICLINIC INTERNATIONAL PLC - Notification of Major Interest in Mediclinic International plc shares

Release Date: 08/05/2018 11:00
Code(s): MEI     PDF:  
Wrap Text
Notification of Major Interest in Mediclinic International plc shares

Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60

8 May 2018

Notification of Major Interest in Mediclinic International plc shares

1a. Identity of the issuer or the underlying issuer                                Mediclinic International plc.                                                                                       
of existing shares to which voting rights are
attached(ii):
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights                                                                   X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:

3. Details of person subject to the notification obligation
                                                         Coronation Asset Management (Pty) Ltd acting as discretionary
Name                                                     investment manager on behalf of managed portfolios.
                                                          
City and country of registered office (if applicable)    Cape Town, South Africa

4. Full name of shareholder(s) (if different from 3.)(v)
Name                                                     N/A

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or
   reached(vi):                                          7 May 2018

6. Date on which issuer notified (DD/MM/YYYY):           7 May 2018

7. Total positions of person(s) subject to the notification obligation
                                                        % of voting rights
                           % of voting rights          through financial                                     Total number of
                           attached to shares             instruments            Total of both in %          voting rights of
                            (total of 8. A)         (total of 8.B 1 + 8.B 2)       (8.A + 8.B)               issuer(vii)                                       
                                                                                                                                                                                                                              
Resulting situation
on the date on which          4.92%                                                   4.92%                   737 243 810                          
threshold was
crossed or reached
Position of previous
notification (if              5.01%                                                   5.01%
applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached(viii)
A: Voting rights attached to shares
Class/type of               Number of voting rights(ix)                           % of voting rights
shares
ISIN code (if possible)            Direct                   Indirect                      Direct                   Indirect
                              (Art 9 of Directive      (Art 10 of Directive          (Art 9 of Directive      (Art 10 of Directive
                            2004/109/EC) (DTR5.1)         2004/109/EC)             2004/109/EC) (DTR5.1)         2004/109/EC)
                                                            (DTR5.2.1)                                             (DTR5.2.1)
GB00B8HX8Z88                36 248 868                                            4.92%

SUBTOTAL 8. A                                 36 248 868                                                4.92%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
                                                                            Number of voting rights
Type of financial           Expiration      Exercise/                       that may be acquired if
instrument                  date(x)         Conversion Period(xi)           the instrument is                % of voting rights
                                                                            exercised/converted.
                                                                               
                                           SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive
2004/109/EC (DTR5.3.1.1 (b))
                                          Exercise/           Physical or
Type of financial       Expiration        Conversion          cash                  Number of
instrument              date(x)           Period (xi)         settlement(xii)       voting rights            % of voting rights
                                                                      
                                                     
                                                                  SUBTOTAL
                                                                  8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not
control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity xiv     X
(please add additional rows as necessary)
                                                                      % of voting rights
                                           % of voting rights         through financial                Total of both if it
                                           if it equals or is         instruments if it                equals or is higher          
Name(xv)                                     higher than the         equals or is higher               than the notifiable 
                                           notifiable threshold      than the notifiable                  threshold            
                                                                          threshold                                                                                                                    
Coronation Fund Managers Ltd
Coronation Investment Management
SA (Pty) Ltd
Coronation Asset Management (Pty)
Ltd                                        4.92%                                                        4.92%


10. In case of proxy voting, please identify:
Name of the proxy holder                                             Coronation Asset Management (Pty) Ltd

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information(xvi)
 
Name: Stephan Kemp
Email: skemp@coronation.co.za
Telephone: +27 21 680 2000

Place of completion         Cape Town, South Africa
Date of completion          7 May 2018

Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary
listings on the JSE in South Africa and the NSX in Namibia.

For further information, please contact:

Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569

Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181

Media queries
FTI Consulting
Brett Pollard/Debbie Scott – UK
+44 (0)20 3727 1000
Sherryn Schooling – South Africa
+27 (0)21 487 9000


Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd

Date: 08/05/2018 11:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story